Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β InhibitionRaphaela Goldbach‐Mansky, Daniel L. Kastner, Christopher Zalewski et al.|New England Journal of Medicine|2006Cited by 902
Treatment Strategies for Deficiency of Adenosine Deaminase 2Amanda K. Ombrello, Daniel L. Kastner, Jing Qin et al.|New England Journal of Medicine|2019Cited by 195
Current and future advances in genetic testing in systemic autoinflammatory diseasesOskar Schnappauf, Ivona Aksentijevich|Lara D. Veeken|2019Cited by 40
The deficiency of adenosine deaminase type 2-results of therapeutic interventionAmanda K. Ombrello, Daniel L. Kastner, Deborah L. Stone et al.|Pediatric Rheumatology|2015Cited by 33